#USA #New York #Medical Devices #Avertix Medical #The Guardian

Avertix Medical to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Avertix Medical, Inc. is set to make waves in the healthcare technology field with its participation in the upcoming Benchmark Company's 13th Annual Discovery One-on-One Investor Conference. This significant event is scheduled for December 11, 2024, and will take place at the esteemed New York Athletic Club in New York City. Avertix, known for its cutting-edge Guardian® system, the first real-time, continuous heart attack detection and patient alerting system, is eager to connect with investors and analysts at this forum.

What to Expect at the Conference

Avertix will have top executives, including President and CEO Tim Moran and Executive Vice President and Chief Financial Officer Philip Tom, engaged in one-on-one meetings throughout the day. This unique format aims to provide both emerging growth companies and established investors an opportunity for deeper understanding and collaboration.

The Benchmark Company is known for its focus on institutional investment, and Avertix’s presentation is structured to highlight the groundbreaking technologies and advancements that the company has achieved in cardiac care. Attendees will get firsthand insights into how Avertix is shaping the future of healthcare technology with its innovative solutions.

The Guardian® System: A Game Changer in Cardiac Care

Avertix Medical has transformed patient care with its Guardian® system, which allows for real-time monitoring and immediate alert in the event of a heart attack. Given that heart disease remains one of the leading causes of death worldwide, this technology represents a critical advancement in timely and potentially life-saving interventions. The Guardian® system is not only FDA-approved but is also supported by a comprehensive portfolio of U.S. patents.

As the conference approaches, Avertix Medical is encouraging interested investors to schedule personal meetings and learn more about their impressive trajectory and future developments. The registration for one-on-one meetings can be completed conveniently online. Potential investors looking to engage with Avertix should visit the registration link: Avertix Registration.

About Avertix Medical, Inc.

Founded with the mission to enhance cardiovascular care, Avertix Medical has been a pioneer in the realm of heart attack detection technology. Their commitment lies in both innovation and improving patient outcomes, ensuring that timely detection translates to better survival rates and healthcare efficiency. For further details about their products and mission, individuals can check out their website at www.avertix.com.

About The Benchmark Company

The Benchmark Company, established in 1988, is a key player in institutional research and investment banking. Based in New York City, they focus on developing strategic partnerships and helping corporate clients achieve long-term success via capital raising, insightful research, and facilitating trading activities within the financial markets. Learn more about their services at www.benchmarkcompany.com.

As the conference unfolds, Avertix Medical's revolutionary heart attack detection technology will take center stage, underscoring the company’s leadership in medical innovation. The opportunity for investors to connect directly with the minds behind these advancements marks a pivotal moment for all stakeholders involved.